Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
European Journal of Hospital Pharmacy : Science and Practice|January 22, 2026
Drug rash with eosinophilia and systemic symptoms: descriptive analysis of pharmacovigilanceEleonora Castellana, Maria Rachele ChiappettaThe Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|May 4, 2026
Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Lenvatinib: A Disproportionality AnalysisEleonora Castellana, Maria Rachele ChiappettaLupus|June 1, 2026
Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosusEleonora Castellana, Maria Rachele ChiappettaThe International Journal of Risk & Safety in Medicine|April 13, 2026
Neuropsychiatric adverse events associated with lorlatinib in ALK-positive NSCLCEleonora Castellana, Maria Rachele ChiappettaThe Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|April 6, 2026
Signals of Toxicity Associated With Gene Therapy: The Case of Etranacogene Dezaparvovec in the Treatment of Hemophilia BEleonora Castellana, Maria Rachele ChiappettaNaunyn-Schmiedeberg'S Archives of Pharmacology|April 8, 2026
Post-marketing safety evaluation and objective benefit-risk assessment of sublingual immunotherapy tablets in allergic rhinitisEleonora Castellana, Maria Rachele ChiappettaHospital Pharmacy|January 9, 2026
Exploring the Potential Link Between Tirzepatide and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): Evidence from FAERS and Google TrendsEleonora Castellana, Maria Rachele ChiappettaHospital Pharmacy|July 22, 2025
Scleroderma: Overview of the Main Advanced Dressings Used in Wound CareEleonora Castellana, Maria Rachele ChiappettaHospital Pharmacy|July 25, 2026
Distribution and Characteristics of Vaccine Adverse Events: Analysis of Over 2 Million Individual Case Safety ReportsEleonora Castellana, Maria Rachele ChiappettaHospital Pharmacy|November 4, 2025
Comparative Analysis of Adverse Drug Reactions Between Oritavancin Diphosphate and Oritavancin-HPβCD Using FAERS DataEleonora Castellana, Maria Rachele ChiappettaPageof 2